MedPath

Efficacy of BCAA food additional intake added to dosage of medicine made of BCAA

Phase 3
Conditions
decompensated cirrhosis
Registration Number
JPRN-UMIN000002888
Lead Sponsor
Hyogo College of Medicine
Brief Summary

o entry

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
0
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patient who doesn't belong to application object of LIVACT 2. Patient who has the past of hepatic encephalopathy 3. Patient who has allergy in element of AMINOFEEL 4. The dietary intake is not enough in anorexia etc. , and the serum albumin is patients who decreased 0.1mg/dL or more in the past two months. 5. Patient who has infectious disease that becomes problem in clinical 6. Patient with serious glucose intolerance, respiratory failure and renal failure 7. Patient inappropriate for participating to this study decided by the attending physicians

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath